Further Analysis of ARRIVE: What are the Perinatal Outcomes Associated with Expectant Management in Low-Risk, Nulliparous Individuals?
BACKGROUND AND PURPOSE:
Tita et al. (Obstetrics & Gynecology, 2021) compared risks of maternal and perinatal outcomes by completed week of gestation from 39 weeks in low-risk nulliparous patients undergoing expectant management
Secondary analysis of the ARRIVE trial
Low risk nulliparous pregnant women
Women who were randomized to the expectant management group and attained 39w0d weeks of gestation in the original ARRIVE trial
39 weeks gestation (39w0d to 39w6d)
40 weeks gestation (40w0d to 40w6d)
41 to 42 weeks gestation (41w0d to 42w2d)
For multivariable analysis, P<.0125 was used to indicate statistical significance for coprimary outcomes
Perinatal composite: Death | Respiratory support | 5-minute Apgar ≤3 | HIE | Seizure | Sepsis | Meconium aspiration syndrome | Birth trauma | Intracranial or subgleal hemorrhage | Hypotension requiring vasopressor support
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan